These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24223153)

  • 1. Direct association of heat shock protein 20 (HSPB6) with phosphoinositide 3-kinase (PI3K) in human hepatocellular carcinoma: regulation of the PI3K activity.
    Matsushima-Nishiwaki R; Kumada T; Nagasawa T; Suzuki M; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Toyoda H; Kozawa O
    PLoS One; 2013; 8(11):e78440. PubMed ID: 24223153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein 20 (HSPB6) regulates apoptosis in human hepatocellular carcinoma cells: Direct association with Bax.
    Nagasawa T; Matsushima-Nishiwaki R; Toyoda H; Matsuura J; Kumada T; Kozawa O
    Oncol Rep; 2014 Sep; 32(3):1291-5. PubMed ID: 24969689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock protein 20 (HSPB6) regulates TNF-α-induced intracellular signaling pathway in human hepatocellular carcinoma cells.
    Nagasawa T; Matsushima-Nishiwaki R; Yasuda E; Matsuura J; Toyoda H; Kaneoka Y; Kumada T; Kozawa O
    Arch Biochem Biophys; 2015 Jan; 565():1-8. PubMed ID: 25447820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression by heat shock protein 20 of hepatocellular carcinoma cell proliferation via inhibition of the mitogen-activated protein kinases and AKT pathways.
    Matsushima-Nishiwaki R; Adachi S; Yoshioka T; Yasuda E; Yamagishi Y; Matsuura J; Muko M; Iwamura R; Noda T; Toyoda H; Kaneoka Y; Okano Y; Kumada T; Kozawa O
    J Cell Biochem; 2011 Nov; 112(11):3430-9. PubMed ID: 21769911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway.
    Matsushima-Nishiwaki R; Toyoda H; Takamatsu R; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Yoshimi N; Kumada T; Kozawa O
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1629-1639. PubMed ID: 28456666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated Heat Shock Protein 20 (HSPB6) Regulates Transforming Growth Factor-α-Induced Migration and Invasion of Hepatocellular Carcinoma Cells.
    Matsushima-Nishiwaki R; Toyoda H; Nagasawa T; Yasuda E; Chiba N; Okuda S; Maeda A; Kaneoka Y; Kumada T; Kozawa O
    PLoS One; 2016; 11(4):e0151907. PubMed ID: 27046040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression levels of heat shock protein 20 decrease in parallel with tumor progression in patients with hepatocellular carcinoma.
    Noda T; Kumada T; Takai S; Matsushima-Nishiwaki R; Yoshimi N; Yasuda E; Kato K; Toyoda H; Kaneoka Y; Yamaguchi A; Kozawa O
    Oncol Rep; 2007 Jun; 17(6):1309-14. PubMed ID: 17487383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
    Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
    Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
    [No Abstract]   [Full Text] [Related]  

  • 9. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced myeloid differentiation factor 88 promotes tumor metastasis via induction of epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Jia RJ; Cao L; Zhang L; Jing W; Chen R; Zhu MH; Guo SW; Wu GB; Fan XY; Wang H; Zhang YY; Zhou XY; Zhao J; Guo YJ
    Cell Death Dis; 2014 Mar; 5(3):e1103. PubMed ID: 24603331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
    Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
    Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
    Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of miR-623 suppresses progression of hepatocellular carcinoma via regulating the PI3K/Akt signaling pathway by targeting XRCC5.
    Ren F; Su H; Jiang H; Chen Y
    J Cell Biochem; 2020 Jan; 121(1):213-223. PubMed ID: 31190447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration.
    Tao CY; Wu XL; Song SS; Tang Z; Zhou YF; Tian MX; Jiang XF; Fang Y; Zhu GQ; Huang R; Qu WF; Gao J; Chu TH; Yang R; Chen JF; Zhao QF; Ding ZB; Dai Z; Zhou J; Liu WR; Shi YH; Fan J
    Cell Oncol (Dordr); 2024 Aug; 47(4):1391-1403. PubMed ID: 38607517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
    Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
    Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients.
    He S; Zhang J; Zhang W; Chen F; Luo R
    J Exp Clin Cancer Res; 2017 Dec; 36(1):175. PubMed ID: 29208003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.
    Liu B; Fang X; Kwong DL; Zhang Y; Verhoeft K; Gong L; Zhang B; Chen J; Yu Q; Luo J; Tang Y; Huang T; Ling F; Fu L; Yan Q; Guan XY
    J Exp Clin Cancer Res; 2022 May; 41(1):182. PubMed ID: 35610614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.